BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $438,000 | -98.7% | 3,180 | -98.7% | 0.00% | -98.5% |
| Q3 2021 | $33,939,000 | +380.4% | 244,326 | +235.7% | 0.06% | +400.0% |
| Q2 2021 | $7,065,000 | +78400.0% | 72,780 | +52639.1% | 0.01% | – |
| Q1 2021 | $9,000 | -99.9% | 138 | -99.9% | 0.00% | -100.0% |
| Q4 2020 | $9,036,000 | +34.5% | 105,422 | +2.0% | 0.02% | +12.5% |
| Q3 2020 | $6,717,000 | +0.4% | 103,321 | +12.9% | 0.02% | -5.9% |
| Q2 2020 | $6,689,000 | +66.7% | 91,498 | -0.2% | 0.02% | +70.0% |
| Q2 2019 | $4,013,000 | -68.3% | 91,638 | -62.7% | 0.01% | -67.7% |
| Q1 2019 | $12,649,000 | +1204.0% | 245,758 | +837.3% | 0.03% | +933.3% |
| Q4 2018 | $970,000 | – | 26,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 2,111,111 | $144,294,000 | 54.16% |
| Knoll Capital Management, LLC | 856,844 | $58,565,000 | 38.16% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,123,271 | $145,126,000 | 21.73% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 860,261 | $58,799,000 | 6.01% |
| ARS Investment Partners, LLC | 561,442 | $38,375,000 | 4.46% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $12,057,000 | 3.19% |
| Eventide Asset Management | 2,015,000 | $137,725,000 | 2.04% |
| Avidity Partners Management LP | 1,049,800 | $71,754,000 | 1.98% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 50,089 | $3,424,000 | 1.87% |
| Nicholas Investment Partners, LP | 375,654 | $25,676,000 | 1.79% |